Fair value (multi-method)
Four independent methods triangulate what ABBV is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$37.58
Method range
$11.72 – $751.59
median $155.41
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $37.58 | -85.16% |
| Exit multiple | $751.59 | +196.72% |
| Analyst target | $273.23 | +7.87% |
| Graham number | $11.72 | -95.37% |
- Forward DCF$37.58
- Exit multiple$751.59
- Analyst target$273.23
- Graham number$11.72
Stock price
$253.30
FCF / share (TTM)
$2.01
3Y FCF CAGR
-5.1%
Fair value @ hist. growth
$30.34
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
20.7%
per year over your projection horizon
Margin of safety -734.9% vs hist-growth DCF
Historical 3Y CAGR
-5.1%
Your model implies
20.7%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -5% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 19.4% | 17.7% | 15.7% | 13.3% | 10.3% |
| 5.1% | 19.7% | 18.1% | 16.2% | 13.9% | 11.0% |
| 6.1% | 23.5% | 22.2% | 20.7% | 19.1% | 17.2% |
| 7.1% | 26.7% | 25.7% | 24.5% | 23.2% | 21.8% |
| 8.1% | 29.6% | 28.8% | 27.8% | 26.7% | 25.6% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$63.8B
Total debt − cash
Beta
0.28
Vs market benchmark
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.